Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Nov 9, 2012, after the close
10-Q filed Nov 9, 2012, 40 days after period end · 0001144204-12-060629
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $170.83K | $103.42K | — |
| Net Income | -$2.58M | -$3.21M | -$3.93M |
| EPS Diluted | -$0.04 | -$0.07 | -$0.09 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
